These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24846971)

  • 21. Clinical and Angiographic Outcomes Comparison of Patients With Left Main Vs Non-Left Main Bifurcation Lesions Treated With Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.
    Vergara R; Valenti R; Migliorini A; Ciabatti M; Grazia De Gregorio M; Taborchi G; Morini S; Rondine R; Martone R; Antoniucci D
    J Invasive Cardiol; 2018 Dec; 30(12):443-446. PubMed ID: 30504512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orbital atherectomy for the treatment of small (2.5mm) severely calcified coronary lesions: ORBIT II sub-analysis.
    Lee MS; Shlofmitz RA; Shlofmitz E; Srivastava PK; Kong J; Grines C; Revytak G; Chambers JW
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):268-272. PubMed ID: 29454531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
    Abdel-Wahab M; Baev R; Dieker P; Kassner G; Khattab AA; Toelg R; Sulimov D; Geist V; Richardt G
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):285-91. PubMed ID: 22431433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery according to the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score.
    Shiyovich A; Perl L; Vaknin-Assa H; Greenberg G; Samara A; Kornowski R; Assali A
    Coron Artery Dis; 2020 Jun; 31(4):336-341. PubMed ID: 31913167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
    Chang TI; Montez-Rath ME; Tsai TT; Hlatky MA; Winkelmayer WC
    J Am Coll Cardiol; 2016 Mar; 67(12):1459-1469. PubMed ID: 27012407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Outcomes of Chronic Total Occlusion Recanalization Versus Percutaneous Coronary Intervention for Complex Non-Occlusive Coronary Artery Disease.
    Azzalini L; Carlino M; Bellini B; Marini C; Pazzanese V; Toscano E; Gramegna M; Moscardelli S; Bognoni L; Montorfano M
    Am J Cardiol; 2020 Jan; 125(2):182-188. PubMed ID: 31759516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries).
    Lee JM; Park KW; Han JK; Yang HM; Kang HJ; Koo BK; Bae JW; Woo SI; Park JS; Jin DK; Jeon DW; Oh SK; Park JS; Kim DI; Hyon MS; Jeon HK; Lim DS; Kim MG; Rha SW; Her SH; Hwang JY; Kim S; Choi YJ; Kang JH; Moon KW; Jang Y; Kim HS
    Am J Cardiol; 2014 Nov; 114(9):1329-38. PubMed ID: 25217457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orbital Atherectomy for the Treatment of Long (≥25-40 mm) Severely Calcified Coronary Lesions: ORBIT II Sub-Analysis.
    Kumar G; Shin EY; Sachdeva R; Shlofmitz E; Behrens AN; Martinsen BJ; Chambers JW
    Cardiovasc Revasc Med; 2020 Feb; 21(2):164-170. PubMed ID: 32014391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry.
    Hemetsberger R; Abdelghani M; Mankerious N; Allali A; Toelg R; Gori T; Achenbach S; Riemer T; Mehilli J; Nef HM; Naber C; Wöhrle J; Zahn R; Kastner J; Schmermund A; Hamm C; Münzel T; Richardt G;
    Coron Artery Dis; 2020 Nov; 31(7):578-585. PubMed ID: 32271247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
    Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
    J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II).
    Huisman J; van der Heijden LC; Kok MM; Danse PW; Jessurun GA; Stoel MG; van Houwelingen KG; Löwik MM; Hautvast RW; IJzerman MJ; Doggen CJ; von Birgelen C
    Am Heart J; 2016 May; 175():121-9. PubMed ID: 27179731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of coronary artery lesion calcification on the long-term outcome of patients with coronary heart disease after percutaneous coronary intervention].
    Zhang Y; Song L; Song Y; Xu LJ; Wang HH; Xu JJ; Tang XF; Jiang P; Liu R; Zhao XY; Gao Z; Gao LJ; Chen J; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jan; 47(1):34-41. PubMed ID: 30669808
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes With Complete Versus Incomplete Revascularization in Patients With Multivessel Coronary Disease Undergoing Percutaneous Coronary Intervention With Everolimus Eluting Stents.
    Bangalore S; Guo Y; Samadashvili Z; Hannan EL
    Am J Cardiol; 2020 Feb; 125(3):362-369. PubMed ID: 31810515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study.
    Barbero U; Kanji R; Cerrato E; Di Summa R; Conrotto F; Kawamoto H; Biondi-Zoccai G; Gili S; Ugo F; Iannaccone M; Gagliardi M; De Benedictis M; Doronzo B; Varbella F; D'Amico M; Moretti C; Colombo A; Escaned J; D'Ascenzo F
    J Invasive Cardiol; 2018 Aug; 30(8):283-288. PubMed ID: 29760284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials.
    Garg S; Sarno G; Girasis C; Vranckx P; de Vries T; Swart M; Bressers M; Garcia-Garcia HM; van Es GA; Räber L; Campo G; Valgimigli M; Dawkins KD; Windecker S; Serruys PW
    JACC Cardiovasc Interv; 2011 Jun; 4(6):645-53. PubMed ID: 21700251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Hiromasa T; Kobayashi Y; Morinaga T; Yamaji K; Soga Y; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):E132-E138. PubMed ID: 26708085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
    Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
    J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.